Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

167.75
+2.391.45%
Post-market: 167.69-0.0600-0.04%19:58 EDT
Volume:9.42M
Turnover:1.58B
Market Cap:43.56B
PE:-11.80
High:168.77
Open:168.01
Low:167.03
Close:165.36
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:1.19
T/O Rate:3.63%
Dividend:2.45
Dividend Rate:1.46%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.27
PE(LYR):-11.80

Loading ...

HCA Healthcare Inc. Stock Climbs 4.9%, Outperforms Peers

Dow Jones
·
Sep 10

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 10

COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating

TIPRANKS
·
Sep 10

'Cut Points' for 2027 Medicare Advantage Plans Look Neutral to Positive, Analysts Say

Reuters
·
Sep 10

Exchange-Traded Funds, US Equities Fall After Midday

MT Newswires Live
·
Sep 10

Sector Update: Healthcare

MT Newswires Live
·
Sep 10

Why Is UnitedHealth Stock (UNH) Down on Wednesday, 9/9/2026?

TIPRANKS
·
Sep 10

Worldwide Healthcare Trust Tightens Capital Base With Share Buyback

TIPRANKS
·
Sep 10

Health Care Roundup: Market Talk

Dow Jones
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

MT Newswires Live
·
Sep 09

UnitedHealth Falls; Cites Pressure in Commercial Business

Reuters
·
Sep 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)

TIPRANKS
·
Sep 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)

TIPRANKS
·
Sep 09

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 09

Abbvie Exec Says Strong Balance Sheet and Long Growth Runway Allow Company to Consider Both Early- and Late-Stage Business Development Opportunities - Conf Call

THOMSON REUTERS
·
Sep 09

Abbvie Exec Says Expects Approval of Subcutaneous Crohn's Disease Treatment in Q4 - Conf Call

THOMSON REUTERS
·
Sep 09

UnitedHealth Shares Down 5.2%

THOMSON REUTERS
·
Sep 09

UnitedHealth, Alphabet Inc. Cl a Share Losses Lead Dow's 350-Point Drop

Dow Jones
·
Sep 09